Physician profile
Yaser Cheema
NPI 1124209663
$8,180.96
in general payments reported to CMS, 2019-2025
32 companies · $1,441 in 2025
The $1,441 reported for 2025 was more than what 78% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,054 · 2020: $374 · 2021: $810 · 2022: $746 · 2023: $935 · 2024: $821 · 2025: $1,441.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,197.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,196.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $1,811.50 | 2019-2020 | |
| Cardiovascular Systems INC. | $1,014.61 | 2019-2022 | |
| Boston Scientific Corporation | $546.11 | 2019-2025 | Avvigo Guidance System, Lux-Dx Insertable Cardiac Monitor, Watchman Access System |
| Abbott Laboratories | $524.98 | 2019-2025 | Esprit, Diamondback Peripheral, Assurity |
| Shockwave Medical, INC | $479.25 | 2022-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Amgen INC. | $386.95 | 2022-2025 | Repatha, Repatha |
| Janssen Pharmaceuticals, INC | $291.07 | 2019-2024 | Xarelto |
| Chiesi USA, INC. | $284.95 | 2019-2020 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $225.32 | 2022-2025 | Lifevest |
| Livanova USA, INC. | $215.83 | 2019 | |
| Philips North America LLC | $211.55 | 2019-2025 | Mcot |
| Actelion Pharmaceuticals US, INC. | $210.02 | 2019-2025 | Opsumit, Uptravi, Opsynvi |
| Medtronic, INC. | $200.10 | 2021-2025 | Symplicity G3, Mycarelink |
| Novartis Pharmaceuticals Corporation | $198.58 | 2019-2024 | |
| Merck Sharp & Dohme LLC | $173.53 | 2022-2023 | Verquvo |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $164.77 | 2019-2023 | Brilinta |
| Teleflex LLC | $149.39 | 2024 | Turnpike |
| Arcutis Biotherapeutics, INC. | $145.25 | 2025 | |
| Terumo Medical Corporation | $144.43 | 2019-2020 | |
| Baxter Healthcare | $131.01 | 2023-2024 | Hillrom - Cardiac Ambulatory Monitor, Hillrom - Carnation Ambulatory Monitor |
| Novo Nordisk INC | $110.88 | 2025 | Ozempic |
| Heartflow, INC. | $78.73 | 2025 | |
| Medicomp INC | $75.89 | 2023 | Telepatch Cardiac Monitor |
| Recor Medical INC | $71.11 | 2025 | Paradise Ultrasound Renal Denervation System |
| Pfizer INC. | $69.10 | 2019-2024 | |
| E.R. Squibb & Sons, L.L.C. | $66.66 | 2019-2023 | Eliquis |
| Kestra Medical Technology Services, INC. | $51.52 | 2025 | Assure Wcd |
| Abiomed | $48.23 | 2024-2025 | Impella |
| Scpharmaceuticals INC. | $34.57 | 2023-2024 | |
| Lexicon Pharmaceuticals, INC. | $31.93 | 2023 | Inpefa |
| Ge Healthcare | $21.99 | 2019 | |
| Vivaquant INC, Dba Rhythm Express | $11.15 | 2025 | Rhythm Express |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Yaser Cheema listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.